Phase III Trial will Assess Ketamine-Assisted Therapy for The Treatment of Severe Alcohol Use Disorder TORONTO, CANADA, 18 April, 2023 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a…

TORONTO, CANADA, April 12, 2023 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use…

Partnership is Awakn’s first with a dedicated addiction treatment clinic, Ken Starr MD Wellness Group TORONTO, CANADA, Feb 28, 2023 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a…

Awakn Will License its Protocols for Treating Addiction and Mental Health to a Healthcare Consortium to Help Accelerate Their Development of a Chain of Clinics in Portugal TORONTO, CANADA, Feb…

Awakn Clinics Trondheim is its second clinic in Norway TORONTO, CANADA, Feb 14, 2023 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to…

TORONTO, CANADA, February 9, 2023 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol…

Designation Aims to Accelerate Time to Market TORONTO, CANADA, February 7, 2023 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to treat addiction…

Study Has Potential to Lead to In-Licensing Agreement and Accelerated Pathway to Phase II TORONTO, CANADA, January 24, 2023 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”),…

And continued successful execution of R&D and Commercialization strategies TORONTO, CANADA, December 15, 2022 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (“Awakn”), a biotechnology company, researching, developing,…

Phase III trial confirmed to cost CA$3.75 million, with UK Government agencies funding 66% of this cost TORONTO, CANADA, 13 Nov, 2022 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF,…

Trondheim in central Norway will be the location of Awakn’s 4th clinic TORONTO, CANADA, Dec 1, 2022 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company…

Awakn’s Nordic expansion begins with new Awakn Clinics Oslo TORONTO, CANADA, Nov 23, 2022 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and…